Clinical trials
Observational Liver Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 9 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 3 |
| Chinese Medical Association | 2 |
| First Affiliated Hospital of Wenzhou Medical University | 2 |
| The Second Affiliated Hospital of Chongqing Medical University | 2 |
| Anhui Provincial Hospital | 1 |
| Children's Hospital of Chongqing Medical University | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Hai Li | 1 |
| Helio Genomics | 1 |
| Hepatopancreatobiliary Surgery Institute of Gansu Province | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Diseases | 23 |
| Acute-On-Chronic Liver Failure | 3 |
| COVID-19 | 3 |
| Carcinoma, Hepatocellular | 2 |
| Hepatitis B | 2 |
| Hepatitis, Viral, Human | 2 |
| Neoplasms | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Bile Duct Diseases | 1 |
| Cholangitis | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.